Evidence map›Paper›PMID 42096245›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2026

[Coffin-Lowry syndrome: Case report in Mexico].

Ana Karen Pérez-Peña, Daniela Juárez-Melchor, Yazmin Hernández-Castañeda

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ana Karen Pérez-PeñaInstituto Mexicano del Seguro Social, Hospital General de Zona No. 20 "La Margarita", Servicio de Patología Clínica. Puebla, Puebla, México.ORCID 0000-0003-0619-5454
Daniela Juárez-MelchorInstituto Mexicano del Seguro Social, Hospital General de Zona No. 20 "La Margarita", Servicio de Genética Médica. Puebla, Puebla, México.ORCID 0000-0001-9060-7241
Yazmin Hernández-CastañedaInstituto Mexicano del Seguro Social, Hospital General de Zona No. 20 "La Margarita", Servicio de Genética Médica. Puebla, Puebla, México.ORCID 0000-0003-1535-4760

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Coffin-Lowry syndrome (CLS, OMIM #303600) is an X-linked dominant inherited condition caused by variants in the RPS6KA3 gene located at Xp22.12 and mainly affects men. It is associated with various phenotypes, including dysmorphic facial features, neurodevelopmental impairment, short stature, and skeletal deformities. The objective was to present a case of CLS, describe the clinical manifestations found, compare it with what is reported in the literature and collaborate in expanding the phenotypic and molecular spectrum, because it presents a previously unreported variant. Clinical case: A 4-year-old male, son of healthy, non-consanguineous parents, who presents distinctive clinical features of CLS: global neurodevelopmental delay, hypertelorism, low-set and prominent ears, down-slanted palpebral fissures, depressed nasal bridge, anteverted nostrils, wide mouth, widely spaced teeth, and broad fingers. Genetic analysis revealed a likely pathogenic hemizygous variant RPS6KA3 c.1762G>A (p. Glu588Lys) associated with CLS. Conclusions: CLS is a rare entity that is usually diagnosed in childhood. Typical facial changes and specific clinical and radiological signs in the hands are very useful in diagnosis.

Indexed as

Coffin-Lowry SyndromeChild, PreschoolHumansMaleMexicoCoffin-Lowry SyndromeCromosoma XEnfermedades RarasRare DiseasesSíndrome de Coffin-LowryX Chromosome

Identifiers

PMID42096245
PMCPMC13193627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.